Brain metastasis in breast cancer: a comprehensive literature review

Breast Cancer Subtypes Predispose the Site of Distant Metastases

(2015) Abha Soni et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Emerging Strategies for Treating Brain Metastases from Breast Cancer

(2015) David P. Kodack et al.   CANCER CELL

Local Control of Brain Metastasis: Treatment Outcome of Focal Brain Treatments in Relation to Subtypes

(2015) Jae Uk Chong et al.   Journal of Breast Cancer

Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases

(2015) R. Duchnowska et al.   NEURO-ONCOLOGY

Outcomes and predictors of improved survival after gamma knife radiosurgery for metastatic brain tumors originated from breast carcinoma

(2015) Shyamal C. Bir et al.   NEUROSURGICAL REVIEW

Breast Cancer With Brain Metastases: Clinicopathologic Features, Survival, and Paired Biomarker Analysis

(2015) Q. Shen et al.   ONCOLOGIST

The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain

(2015) Rajendra P. Pangeni et al.   Clinical Epigenetics

Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy

(2015) José Pablo Leone et al.   Cancer Medicine

Predictors for Long-Term Survival Free from Whole Brain Radiation Therapy in Patients Treated with Radiosurgery for Limited Brain Metastases

(2015) Daniel Gorovets et al.   Frontiers in Oncology

Identification of breast cancer patients with a high risk of developing brain metastases: a single-institutional retrospective analysis

(2014) Volker Rudat et al.   BMC CANCER

Outcome of triple negative breast cancer: comparison of sporadic and BRCA1-associated cancers

(2014) Nadine Tung et al.   BREAST CANCER RESEARCH AND TREATMENT

Prognostic factors of HER2-positive breast cancer patients who develop brain metastasis: a multicenter retrospective analysis

(2014) Naoki Hayashi et al.   BREAST CANCER RESEARCH AND TREATMENT

Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis

(2014) Naoki Niikura et al.   BREAST CANCER RESEARCH AND TREATMENT

Brain metastasis from ovarian cancer: a systematic review

(2014) Shabnam Pakneshan et al.   JOURNAL OF NEURO-ONCOLOGY

Distinct MR Imaging Features of Triple-Negative Breast Cancer with Brain Metastasis

(2014) Ren-Hua Yeh et al.   JOURNAL OF NEUROIMAGING

Safety Profile of Pertuzumab With Trastuzumab and Docetaxel in Patients From Asia With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Results From the Phase III Trial CLEOPATRA

(2014) Sandra M. Swain et al.   ONCOLOGIST

Prognostic factors in patients with metastatic breast cancer at the time of diagnosis

(2014) Zhiyong Ren et al.   PATHOLOGY RESEARCH AND PRACTICE

Effect of Age and Biological Subtype on the Risk and Timing of Brain Metastasis in Breast Cancer Patients

(2014) Man-Hsin Hung et al.   PLoS One

Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab

(2013) E. M. Olson et al.   ANNALS OF ONCOLOGY

Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial

(2013) E. de Azambuja et al.   ANNALS OF ONCOLOGY

Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome

(2013) Dorien J. A. Lobbezoo et al.   BREAST CANCER RESEARCH AND TREATMENT

The number of involved extracranial organs: A new predictor of survival in breast cancer patients with brain metastasis

(2013) Lavinia Gerdan et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

The proinflammatory peptide substance P promotes blood-brain barrier breaching by breast cancer cells through changes in microvascular endothelial cell tight junctions

(2013) Pedro L. Rodriguez et al.   INTERNATIONAL JOURNAL OF CANCER

The factors that have an impact on the development of brain metastasis in the patients with breast cancer

(2013) Dogan Koca et al.   Journal of Cancer Research and Therapeutics

Systemic treatment after whole-brain radiotherapy may improve survival in RPA class II/III breast cancer patients with brain metastasis

(2013) Qian Zhang et al.   JOURNAL OF NEURO-ONCOLOGY

Survival following gamma knife radiosurgery for brain metastasis from breast cancer

(2013) Jerry J Jaboin et al.   Radiation Oncology

Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology

(2013) Muhammet Ali Kaplan et al.   Breast Cancer

The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival

(2012) Mustafa Oktay Tarhan et al.   CLINICAL & EXPERIMENTAL METASTASIS

Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study

(2012) Thomas Bachelot et al.   LANCET ONCOLOGY

Bevacizumab in the treatment of five patients with breast cancer and brain metastases: Japan Breast Cancer Research Network-07 trial

(2012) Daigo Yamamoto et al.   OncoTargets and Therapy

Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancer

(2011) S. Gori et al.   ANNALS OF ONCOLOGY

Breast cancer subtypes and outcomes of central nervous system metastases

(2011) Ulku Y. Arslan et al.   BREAST

Clinical features and course of brain metastases in triple-negative breast cancer: comparison with human epidermal growth factor receptor 2-positive and other type at single institution in Korea

(2011) Geundoo Jang et al.   BREAST CANCER RESEARCH AND TREATMENT

Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse

(2011) J. Chuck Harrell et al.   BREAST CANCER RESEARCH AND TREATMENT

Factors associated with mortality after breast cancer metastasis

(2011) Su Yon Jung et al.   CANCER CAUSES & CONTROL

Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors

(2011) Naoki Niikura et al.   JOURNAL OF CLINICAL ONCOLOGY

Incidence of and survival following brain metastases among women with inflammatory breast cancer

(2010) S. Dawood et al.   ANNALS OF ONCOLOGY

Nomogram to Predict Subsequent Brain Metastasis in Patients With Metastatic Breast Cancer

(2010) Olivier Graesslin et al.   JOURNAL OF CLINICAL ONCOLOGY

Deconstructing the molecular portraits of breast cancer

(2010) Aleix Prat et al.   Molecular Oncology

Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer

(2009) Rupert Bartsch et al.   BMC CANCER

Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but notHER2/neu-positive breast cancer

(2009) Kan Yonemori et al.   CANCER

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer

(2009) N. U. Lin et al.   CLINICAL CANCER RESEARCH

Genes that mediate breast cancer metastasis to the brain

(2009) Paula D. Bos et al.   NATURE

Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization

(2008) Daniel P. Fitzgerald et al.   CLINICAL & EXPERIMENTAL METASTASIS